Keywords: ضد انعقاد خوراکی; Stroke; dabigatran; rivaroxaban; apixaban; edoxaban; oral anticoagulants;
مقالات ISI ضد انعقاد خوراکی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ضد انعقاد خوراکی; Oral anticoagulants; Oral contraceptive; Thrombosis; Bleeding;
Keywords: ضد انعقاد خوراکی; Coronary artery disease; Medicare; Non-valvular atrial fibrillation; Oral anticoagulants; Peripheral artery disease; Stroke;
Keywords: ضد انعقاد خوراکی; Anticoagulation-related intracerebral hemorrhage; anticoagulation reversal; intracerebral hemorrhage; coagulopathy; oral anticoagulants; door to reversal;
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Factor Xa inhibitors; Oral anticoagulants; Thrombin inhibitors;
Keywords: ضد انعقاد خوراکی; Anticoagulantes orales; Fibrilación auricular; Enfermedad renal crónica; Oral anticoagulants; Atrial fibrillation; Chronic kidney disease;
Keywords: ضد انعقاد خوراکی; Oral anticoagulants; Atrial fibrillation; Chronic kidney disease; Anticoagulantes orales; Fibrilación auricular; Enfermedad renal crónica;
Keywords: ضد انعقاد خوراکی; Stroke; In-hospital mortality; Ischaemic stroke; Haemorrhagic stroke; Acute coronary syndrome; Oral anticoagulants; Ictus; Mortalidad intrahospitalaria; Ictus isquémico; Ictus hemorrágico; SÃndrome coronario agudo; Anticoagulación oral;
Keywords: ضد انعقاد خوراکی; Ictus; Mortalidad intrahospitalaria; Ictus isquémico; Ictus hemorrágico; SÃndrome coronario agudo; Anticoagulación oral; Stroke; In-hospital mortality; Ischaemic stroke; Haemorrhagic stroke; Acute coronary syndrome; Oral anticoagulants;
Keywords: ضد انعقاد خوراکی; atrial fibrillation; major bleeding; oral anticoagulants; postmarketing drug safety; aRR; adjusted relative risk; DOAC; direct oral anticoagulant;
Keywords: ضد انعقاد خوراکی; efficacy; heart failure; non vitamin-K oral anticoagulants; oral anticoagulants; safety;
Keywords: ضد انعقاد خوراکی; Oral anticoagulants; Ischaemic stroke; International normalized ratio; Cardioembolic strokeAnticoagulantes orales; Ictus isquémico; Cociente internacional normalizado; Ictus cardioembólico
Keywords: ضد انعقاد خوراکی; A/C; oral anticoagulants; APC; activated protein C; BMI; Body Mass Index; CRP; C-reactive protein; DVT; deep vein thrombosis; EDTA; ethylenediaminetetraacetic acid; ELISA; enzyme-linked immunosorbent assay; FXIII; Factor XIII; HI; healthy individuals; IQR
Keywords: ضد انعقاد خوراکی; Oral anticoagulants; Coagulation testing; Trough level; Anticoagulant effect;
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Stroke risk; Bleeding risk; Antithrombotic prophylaxis; Oral anticoagulants; Antiplatelet drugs;
Keywords: ضد انعقاد خوراکی; Anticoagulation reversal; Gastrointestinal bleeding; Oral anticoagulants;
Keywords: ضد انعقاد خوراکی; extraction; oral anticoagulants; tranexamic acid; warfarin;
Keywords: ضد انعقاد خوراکی; Cancer; Venous thromboembolism; Treatment; Low-molecular-weight-heparin; Oral anticoagulants; Network meta analysis
Keywords: ضد انعقاد خوراکی; NOAC; oral anticoagulants; prescribing trends;
Keywords: ضد انعقاد خوراکی; Aspirin; Apixaban; Dabigatran; Edoxaban; Rivaroxaban; Oral anticoagulants; Pulmonary embolism; Venous thromboembolism; Venous thrombosis
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Guidelines; Oral anticoagulants; Rate control; Rhythm control; Survival;
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Stroke; Oral anticoagulants;
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Stroke risk; Bleeding risk; Antithrombotic prophylaxis; Oral anticoagulants; Antiplatelet drugs;
Keywords: ضد انعقاد خوراکی; Stroke prevention; Atrial fibrillation; Oral anticoagulants;
Keywords: ضد انعقاد خوراکی; AF; atrial fibrillation; cW; continuous warfarin; dOAC; discontinued warfarin; LA; left atrium; NOAC; new oral anticoagulants; OAC; oral anticoagulation; RF; radiofrequency; VKA; vitamin K antagonists; Atrial fibrillation; Catheter ablation; Heparin; Oral
Keywords: ضد انعقاد خوراکی; Home treatment; Oral anticoagulants; Pulmonary embolism; Venous thromboembolism
Keywords: ضد انعقاد خوراکی; atrial fibrillation; chronic kidney disease; oral anticoagulants; venous thromboembolism
Spontaneous epidural hematoma of the spine associated with oral anticoagulants: 3 Case Studies
Keywords: ضد انعقاد خوراکی; Spontaneous epidural hematoma of the spine; Oral anticoagulants; Acenocoumarol
Epistaxis complicating treatment by anti-vitamin K and new oral anticoagulants
Keywords: ضد انعقاد خوراکی; Epistaxis; Rivaroxaban; Dabigatran; Oral anticoagulants;
Thrombolysis with rt-PA under Rivaroxaban Anticoagulation in a Hypertensive Rat Model of Intraluminal Middle Cerebral Artery Occlusion
Keywords: ضد انعقاد خوراکی; Cerebral infarction; Fibrinolysis; Oral anticoagulants; Rat;
Biobarcode assay for the oral anticoagulant acenocoumarol
Keywords: ضد انعقاد خوراکی; NP-based biobarcode; Small molecule; Acenocoumarol; Therapeutic drug monitoring; Oral anticoagulants; Immunoassay;
Factores pronósticos y análisis de la mortalidad de las hemorragias cerebrales asociadas a anticoagulantes orales antagonistas de la vitamina K. Resultados del Estudio TAC Registry
Keywords: ضد انعقاد خوراکی; Hemorragia cerebral; Anticoagulantes orales; Acenocumarol; Warfarina; Mortalidad; Intracranial haemorrhage; Oral anticoagulants; Acenocoumarol; Warfarin; Mortality;
Prognostic factors and analysis of mortality due to brain haemorrhages associated with vitamin K antagonist oral anticoagulants. Results from the TAC Registry
Keywords: ضد انعقاد خوراکی; Intracranial haemorrhage; Oral anticoagulants; Acenocoumarol; Warfarin; Mortality; Hemorragia cerebral; Anticoagulantes orales; Acenocumarol; Warfarina; Mortalidad;
Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury
Keywords: ضد انعقاد خوراکی; atrial fibrillation; drug-induced liver injury; oral anticoagulants; population-based; CI; confidence interval; HR; hazard ratio; ICD-10-CA; International Classification of Diseases-10th Revision, for Canada; ISQ; Institut de la statistique du Québec; ME
Tromboc@t Working Group recommendations for management in patients receiving direct oral anticoagulants
Keywords: ضد انعقاد خوراکی; Direct; oral anticoagulants; Atrial fibrillation; Venous thromboembolism; Recommendations; Reversal; Anticoagulantes orales directos; Fibrilación auricular; Tromboembolismo venoso; Recomendaciones; Reversión;
Recomendaciones del Grupo Catalán de Trombosis (Tromboc@t Working Group) para el tratamiento de los pacientes que reciben anticoagulantes orales directos
Keywords: ضد انعقاد خوراکی; Anticoagulantes orales directos; Fibrilación auricular; Tromboembolismo venoso; Recomendaciones; Reversión; Direct; oral anticoagulants; Atrial fibrillation; Venous thromboembolism; Recommendations; Reversal;
State of play and future direction with NOACs: An expert consensus
Keywords: ضد انعقاد خوراکی; Oral anticoagulants; Pulmonary embolism; Deep vein thrombosis; Atrial fibrillation; Expert consensus;
Calciphylaxis: Beyond CKD-MBD
Keywords: ضد انعقاد خوراکی; Calciphylaxis; Chronic renal failure; Mortality; Non-renal forms; Oral anticoagulants; Calcifilaxis; Insuficiencia renal crónica; Mortalidad; Formas no renales; Anticoagulantes orales;
Calcifilaxis: más allá de CKD-MBD
Keywords: ضد انعقاد خوراکی; Calcifilaxis; Insuficiencia renal crónica; Mortalidad; Formas no renales; Anticoagulantes orales; Calciphylaxis; Chronic renal failure; Mortality; Non-renal forms; Oral anticoagulants;
Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Oral anticoagulants; Stroke; Intracranial bleeding; Gastrointestinal bleeding;
Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report
Keywords: ضد انعقاد خوراکی; Atrial fibrillation (AF); nonvalvular AF; bleeding; chronic kidney disease (CKD); CKD stage 5D; dialysis; hemodialysis; dialysis-dependent CKD; Kidney Disease Outcomes Quality Initiative (KDOQI); oral anticoagulants; peritoneal dialysis; stroke; warfarin;
Mechanical mitral valve prosthesis: Should the INR be above 2 when aspirin is added to the oral anticoagulant?
Keywords: ضد انعقاد خوراکی; Mechanical mitral valve; Aspirin; Oral anticoagulants;
Pharmacogenetics of dabigatran etexilate interindividual variability
Keywords: ضد انعقاد خوراکی; Oral anticoagulants; Dabigatran; Genetics; Polymorphisms
New antithrombotic therapies and complementary and alternative medicine (CAM): Chartering into unknown territory
Keywords: ضد انعقاد خوراکی; Complementary and alternative medicine; Oral anticoagulants; New oral anticoagulants; Antiplatelets; New antiplatelets; Antithrombotics;
Heparin supplement counteracts the prohemostatic effect of prothrombin complex concentrate and factor IX concentrate: An in vitro evaluation
Keywords: ضد انعقاد خوراکی; Oral anticoagulants; Hemophilia B; Rivaroxaban; Vitamin K-dependent factors; Blood products
Anticoagulants d'action directe: une revue de la littérature des études coût/efficacité en Europe
Keywords: ضد انعقاد خوراکی; Coût/efficacité; Fibrillation atriale; Anticoagulants oraux; Comparaison internationaleCost-effectiveness; Atrial fibrillation; Oral anticoagulants; International comparison
Will NOACs become the new standard of care in anticoagulation therapy?
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Warfarin; Oral anticoagulants
L'anticoagulation du patient âgé en fibrillation atriale : que prescrivent les cardiologues, les gériatres et les médecins généralistes ?
Keywords: ضد انعقاد خوراکی; Fibrillation atriale; Traitement anticoagulant; Anticoagulants oraux; Anti-vitamine K; Anticoagulant oraux directs; Recommandations; Atrial fibrillation; Anticoagulation therapy; Oral anticoagulants; Antivitamin-K; Oral direct anticoagulant; Guidelines;
Thromboembolic Prevention in Frail Elderly Patients With Atrial Fibrillation: A Practical Algorithm
Keywords: ضد انعقاد خوراکی; Elderly; frailty; atrial fibrillation; stroke prevention; bleeding risk; oral anticoagulants;
Quality of Vitamin K Antagonist Anticoagulation in Spain: Prevalence of Poor Control and Associated Factors
Keywords: ضد انعقاد خوراکی; Nonvalvular atrial fibrillation; Oral anticoagulants; Vitamin K antagonists; Rosendaal methodFibrilación auricular no valvular; Anticoagulantes orales; Antagonistas de la vitamina K; Método de RosendaalINR, international normalized ratio; NVAF, nonvalvula